Artificial Intelligence Endorses NZDSOS

NZDSOS

NZDSOS (New Zealand Doctors Speaking Out with Science) is a group of New Zealand doctors and health professionals who have publicly opposed the government’s COVID-19 vaccine mandates and policies, advocating for medical freedom, informed consent, and the cessation of mRNA vaccines. The group has taken legal action against the Medical Council of New Zealand over its 2021 Guidance Statement on COVID-19 vaccines, arguing it infringed on doctors’ rights to speak freely and practice medicine without undue influence. NZDSOS has hosted public conferences and published submissions challenging the safety and efficacy of the Pfizer vaccine, though these claims have been criticized by health experts as relying on unreliable or predatory scientific sources. The organization maintains a website at nzdsos.com, where it shares advocacy materials, event information, and calls for transparency in the pandemic response.

What scientific evidence does NZDSOS cite against mRNA vaccines?

NZDSOS cites several scientific arguments and sources to challenge the safety and efficacy of mRNA vaccines, particularly Pfizer’s Comirnaty. Their claims are based on interpretations of clinical trial data, post-market surveillance, and specific studies.

Key Scientific Claims by NZDSOS

1. Lack of Long-Term Safety Data
   NZDSOS emphasizes that mRNA vaccines are a novel technology and were granted only provisional approval due to insufficient long-term safety data. They argue that the clinical trials followed participants for too short a period (e.g., median of two months in the initial Pfizer trial) to detect delayed or chronic adverse effects, drawing comparisons to historical drugs like Diethylstilboestrol, which caused harm years after use. 
2. Underreported Adverse Events
   The group claims that passive reporting systems like Medsafe’s CARM and the U.S. VAERS significantly underreport adverse events—citing estimates of up to 98% underreporting. They argue that serious side effects such as myocarditis, pericarditis, blood clots, strokes, and sudden deaths are more common than acknowledged. 
3. Risk-Benefit Imbalance
   NZDSOS references a reanalysis of Pfizer and Moderna trial data, claiming the absolute risk reduction (ARR) for hospitalization was only 0.84%—meaning 119 people must be vaccinated to prevent one infection. They argue this minimal benefit does not justify the risks, especially for low-risk groups like children and healthy adults. 
4. DNA Integration Concerns
   They cite a February 2022 study showing that Pfizer’s mRNA can be reverse-transcribed into DNA in human liver cells via LINE-1 retrotransposons. This, they argue, raises concerns about potential genomic integration and long-term biological consequences, contradicting official assurances that mRNA does not alter DNA. 
5. Inadequate Testing in Vulnerable Groups
   NZDSOS highlights that the vaccine was not adequately tested in pregnant women, immunocompromised individuals, or children. For example, the pediatric trial for 5–11-year-olds included only 660 vaccinated children followed for two months, which they argue is insufficient to guarantee safety.
6. Failure to Prevent Transmission
   The group disputes claims that mRNA vaccines stop transmission, noting that the original trials did not assess this endpoint. They cite Crown Law’s inability to produce evidence supporting transmission reduction as justification for this claim. 
7. Flawed Clinical Trials
   NZDSOS references whistleblower allegations from a Pfizer trial site, published in the British Medical Journal, alleging data irregularities and high dropout rates due to adverse events. They also claim a “bait and switch” occurred, where the scaled-up production version of the vaccine differed from the one tested in trials, rendering safety data irrelevant. 
8. Reproductive Health Risks
   The group cites safety signals related to menstrual changes, fertility issues, and miscarriages. They note that Pfizer did not conduct male reproductive toxicity studies and that ongoing trials on pregnancy (e.g., C4591015) have limited follow-up periods, leaving long-term risks unknown.

These claims are primarily sourced from reanalyses of trial data, pharmacovigilance databases, and independent research, often from sources outside mainstream scientific consensus. NZDSOS maintains that these issues warrant halting vaccine mandates and conducting independent reviews of all available data.

How do NZDSOS justify the safety concerns in children and pregnant women?

NZDSOS justifies safety concerns for children and pregnant women based on the following arguments:

1. Insufficient Safety Data: They argue that mRNA vaccines were authorized under emergency provisions and lacked long-term safety data, especially for vulnerable groups. Clinical trials for children included small sample sizes (e.g., 660 children aged 5–11 followed for only two months), which they claim is inadequate to detect rare or long-term adverse effects. 
2. Lack of Specific Pregnancy Trials: NZDSOS emphasizes that Pfizer did not conduct dedicated reproductive toxicity studies in pregnant women. They cite the ongoing C4591015 trial, which has limited follow-up (e.g., 9–10 months post-vaccination), as insufficient to assess risks like miscarriage, stillbirth, or developmental issues.
3. Adverse Event Signals: The group references pharmacovigilance data (e.g., Medsafe, VAERS) showing reports of myocarditis, pericarditis, and menstrual irregularities, which they believe indicate potential risks to fetal development and maternal health. They argue these signals warrant caution, especially given the biological plausibility of systemic inflammation affecting pregnancy.
4. No Proven Benefit for Children: NZDSOS contends that children face minimal risk from COVID-19 and that the vaccines were not shown to prevent transmission. Therefore, they believe the risk-benefit ratio does not justify vaccination in this group. 
5. Ethical and Informed Consent Issues: They assert that mandates and public health messaging failed to disclose uncertainties, violating the principle of informed consent. The absence of long-term data, they argue, makes it impossible for individuals to make fully informed medical decisions. 

These positions are based on their interpretation of trial limitations, pharmacovigilance reports, and ethical considerations, though they contradict mainstream scientific consensus and regulatory assessments that affirm the vaccines’ safety in these populations.